Logo

Qiagen To Market HLA Typing Technology from Genome Diagnostics

Oct 10, 2006
NEW YORK (GenomeWeb News) – Qiagen secured commercial rights to sell reagents and software for Genome Diagnostics' sequencing based typing technology, Genome Diagnostics said yesterday.
 
The Dutch company has developed a proprietary strategy for typing human leukocyte antigen genes. Qiagen will have global distribution rights to the technology as of January 2007.
 
Qiagen already has an exclusive sales and distribution agreement to distribute with Olerup SSP's HLA sequence specific primer technology for HLA typing, Genome Diagnostics said. With this agreement, Qiagen can offer both products to researchers for a complete HLA typing solution.
 

Financial details were not disclosed.

Breaking News
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.